Study Summary
This trial will compare the benefits of two different types of strength training for people with Multiple Sclerosis.
- Multiple Sclerosis
- Clinical Trial
- Blood Flow Restriction
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
5 Primary · 1 Secondary · Reporting Duration: Day 3, Week 4 and 8, Day 29
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Standard of Care
1 of 2
Blood Flow Restriction
1 of 2
Active Control
Experimental Treatment
30 Total Participants · 2 Treatment Groups
Primary Treatment: Blood Flow Restriction · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 55 · Female Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
Florida | 100.0% |
How old are they?
18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
Met criteria | 100.0% |
Frequently Asked Questions
Are there still opportunities available to participate in this research project?
"That is correct. The information available on clinicaltrials.gov reveals that this trial is currently seeking participants. This study was first posted on January 1st, 2022 and was last updated on December 15th, 2021. They are looking for 30 individuals from 1 location." - Anonymous Online Contributor
Is this research project limited to a certain age demographic?
"The age limit for participants in this study is 55 years old. All participants must also be older than 18 years old." - Anonymous Online Contributor
Would I be able to join this research project if I qualify?
"Eligible participants for this study must be between 18-55 years old, have a current diagnosis of multiple sclerosis, a female sex, an Expanded Disability Status Score of 6.5 or lower, the ability to walk unassisted for 10 meters, and the commitment to attend all 29 testing sessions over the 14 weeks that the trial will take place." - Anonymous Online Contributor